MENU
TRAW
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Traws Pharma (TRAW) Ownership - Who owns Traws Pharma?

Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
12 Penns Trail
Phone
+1 267 759-3680
Employees
17
Web
https://www.onconova.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.9M
P/E Ratio
N/A
Total Cash
15.94M
Projected Growth
N/A
Total Debt
N/A
Revenue
227K
Risk (Beta)
1.50
Dividend Yield
N/A
Total Cash/Share
2.86
Total Debt/Equity
N/A
Revenue/Share
0.07 USD as % of share price

Fundamentals

TRAW
Capitalization
7.9M
P/E Ratio
N/A
Risk (Beta)
1.50
Dividend Yield
N/A
Total Cash
15.9M
Total Cash/Share
2.86
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.07%
Revenue
227K
ROE
N/A
Book Value
6M
P/B Ratio
1.32
Cash Flow
N/A
Earnings
-27.12
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
50K
Current Ratio
1.81
Current Revenue Per Employee
8142.86
Dividends Per Share - Security
N/A
EBITDA
-24.89M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-151.48
Shares Held By Institutions
4.1M
Shares Outstanding - Current
5.56M
Total Liabilities
13.1M
Total Volume MTD
N/A
Value
1
Gain YTD
-84.009
View a ticker or compare two or three
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which engages in the identification and development of oncology therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
12 Penns Trail
Phone
+1 267 759-3680
Employees
17
Web
https://www.onconova.com